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BeBACKGROUND Blood ﬂow in the intestinal arteries is reduced in patients with stable heart failure (HF) and relates to
gastrointestinal (GI) symptoms and cardiac cachexia.
OBJECTIVES The aims of this study were to measure arterial intestinal blood ﬂow and assess its role in juxtamucosal
bacterial growth, GI symptoms, and cachexia in patients with HF.
METHODS A total of 65 patients and 25 controls were investigated. Twelve patients were cachectic. Intestinal blood
ﬂow and bowel wall thickness were measured using ultrasound. GI symptoms were documented. Bacteria in stool and
juxtamucosal bacteria on biopsies taken during sigmoidoscopy were studied in a subgroup by ﬂuorescence in situ
hybridization. Serum lipopolysaccharide antibodies were measured.
RESULTS Patients showed 30% to 43% reduced mean systolic blood ﬂow in the superior and inferior mesenteric ar-
teries and celiac trunk (CT) compared with controls (p < 0.007 for all). Cachectic patients had the lowest blood ﬂow (p <
0.002). Lower blood ﬂow in the superior mesenteric artery and CT was correlated with HF severity (p < 0.04 for all).
Patients had more feelings of repletion, ﬂatulence, intestinal murmurs, and burping (p < 0.04). Burping and nausea or
vomiting were most severe in patients with cachexia (p < 0.05). Patients with lower CT blood ﬂow had more abdominal
discomfort and immunoglobulin A–antilipopolysaccharide (r ¼ 0.76, p < 0.02). Antilipopolysaccharide response was
correlated with increased growth of juxtamucosal but not stool bacteria. Patients with intestinal murmurs had greater
bowel wall thickness of the sigmoid and descending colon, suggestive of edema contributing to GI symptoms (p < 0.05).
In multivariate regression analysis, lower blood ﬂow in the superior mesenteric artery, CT (p < 0.04), and inferior
mesenteric artery (p ¼ 0.056) was correlated with the presence of cardiac cachexia.
CONCLUSIONS Intestinal blood ﬂow is reduced in patients with HF. This may contribute to juxtamucosal bacterial
growth and GI symptoms in patients with advanced HF complicated by cachexia. (J Am Coll Cardiol 2014;64:1092–102)
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AB BR E V I A T I O N S
AND ACRONYM S
ANP = atrial natriuretic
peptide
CT = celiac trunk
GI = gastrointestinal
HF = heart failure
IgA = immunoglobulin A
IMA = inferior mesenteric
artery
LVEF = left ventricular
ejection fraction
LPS = Lipopolysaccharide
NYHA = New York Heart
Association
SMA = superior mesenteric
artery
TAMV = time-averaged
velocity
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1093in patients with chronic HF ranges from 16% to
42% (2).
The role of the gut in the pathophysiology of
chronic HF has only recently undergone detailed in-
vestigations. There is increasing evidence that the gut
plays an important pathophysiological role in
malnutrition and cachexia in chronic HF. Signiﬁcant
morphological and functional alterations of the
intestine in patients with chronic HF have been pre-
viously shown (3). Patients display a thickened bowel
wall, suggestive of bowel wall edema; intestinal bar-
rier dysfunction; and diminished transcellular trans-
port activity (4). There are increased numbers of
bacteria in the mucus layer adjacent to the apical
surface of the colonic mucosa, and increased perme-
ability of both the small and large intestines has
been demonstrated. Restricted arterial blood ﬂow to
the intestine is a major candidate explaining these
functional alterations and may create an abnormal
environment in the juxtamucosal mucus layer that
encourages the increased growth of bacteria. How-
ever, arterial blood ﬂow to the intestine and gas-
trointestinal (GI) symptoms in cachectic and
noncachectic patients with HF has not yet been
analyzed.SEE PAGE 1103We hypothesized that arterial blood ﬂow in the
main intestinal arteries is reduced in patients with
stable compensated HF and relates to possible GI
symptoms and to the prevalence of cardiac cachexia.
METHODS
We prospectively studied intestinal blood ﬂow in 65 pa-
tients with chronic HF and 25 control subjects. De-
mographic and clinical details are shown in Table 1. The
diagnosis of chronic HF was based on symptoms arising
during exercise, clinical signs, and documented left ven-
tricular impairment (left ventricular ejection fraction
[LVEF] # 40%) according to guidelines (5). Patients were
classiﬁed as cachectic independent of their absolute body
mass indexes if they had experienced nonedematous un-
intentional weight loss of$5%within the previous 6 to 12Investigating Co-Morbidities Aggravating Heart Failure by the Seventh Fra
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(mean New York Heart Association [NYHA] func-
tional class 2.5  0.5) and received unchanged
medications for at least 4 weeks before assess-
ments. Patients were allowed to take aspirin 100
mg once daily but no other nonsteroidal anti-
inﬂammatory drugs, steroid hormones, or anti-
biotics within at least 4 weeks before study
participation. In patients with HF, medications
consisted of angiotensin-converting enzyme in-
hibitors (71%), angiotensin receptor blockers
(32%), beta-blockers (88%), aldosterone receptor
antagonists (52%), other diuretic agents (72%),
glycoside agents (20%), and statins (80%) in
varying combinations. None of the control sub-
jectswere taking any cardiovascularmedications,
except for a calcium channel blocker in 1 subject
and angiotensin-converting enzyme inhibitors in
2 subjects for mild arterial hypertension without
evidence of left ventricular dysfunction. Subjects with
clinical signs of infection, rheumatoid arthritis, renal fail-
ure, intestinal diseases, severe chronic obstructive pul-
monary disease, signiﬁcant valvular heart disease, cancer,
orhistoriesof autoimmunedisorderswereexcluded.None
of the subjects had known immune system disorders, and
no subject received immune modulation therapy.
The local ethics committee approved the study, and all
subjects gave written informed consent.
CLINICAL ASSESSMENTS. Echocardiography was
performed according to standard procedures. LVEF
was measured using the biplane Simpson’s tech-
nique. All subjects underwent symptom-limited
treadmill exercise testing (instantaneous breath-
by-breath method) using the modiﬁed Naughton
protocol (Innocor system [Innovision, Odense,
Denmark]; HP Cosmos treadmill [HP Cosmos Sports &
Medical GmbH, Nussdorf-Traunstein, Germany]).
The following variables were measured: peak
oxygen consumption, total exercise time, ventilatory
response to exercise, anaerobic threshold, peak heart
rate, and peak systolic and diastolic blood pressures.
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erior mesenteric artery (SMA), and inferior mesenteric
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TABLE 1 Baseline Data for Patients With Chronic HF With and Without Cachexia and Control Subjects
Controls
(n ¼ 25)
All Patients With
Chronic HF
(n ¼ 65)
Patients With Noncachectic
Chronic HF
(n ¼ 53)
Patients With Cachectic
Chronic HF
(n ¼ 12) p Value*
Women 28 15 17 8 0.70
NYHA functional class 2.5  0.5 2.4  0.5 2.9  0.4 0.009
Ischemic etiology 74 77 58 0.40
Ejection fraction, % 63  7 30  7† 31  7† 25  7† 0.006
Age, yrs 62  10 65  10 66  9 64  9 0.50
Body mass index, kg/m2 26  4 28  5 29  5† 25  5 0.02
Height, cm 174  8 174  8 175  9 171  8 0.20
Weight, kg 79  15 86  19 89  19† 74  17 0.01
Peak VO2, ml/min/kg 27.4  7.2 15.2  4.6† 15.8  4.6† 12.7  4.1† 0.09
Hemoglobin, g/dl 13.7  1.5 13.6  1.7 13.9  1.6 12.2  1.5† 0.007
Hematocrit, % 40.5  3.0 40.6  4.5 41.2  4.5 37.3  3.6 0.01
White blood cells, 109/l 6.4  1.4 7.3  1.7† 7.4  1.9† 7.0  1.0 0.50
Creatinine, mg/dl 0.9  0.2 1.2  0.3 1.2  0.3 1.2  0.4 0.60
ASAT, U/l 27.8  7.6 29.1  8.4 29.2  7.4 29.3  12.4 0.90
ALAT, U/l 26.3  14.4 25.9  13.1 27.0  13.7 21.5  9.4 0.20
C-reactive Protein, mg/dl 3.0 (2.2) 3.1 (7.7)† 3.0 (0.5) 13.5 (15.1)† 0.01
Midregional pro-ANP, nmol/l 75 (48) 217 (217)† 178 (160)† 410 (321)† 0.0008
Midregional proadrenomedullin, nmol/l 0.5  0.1 1.0  0.5† 0.9  0.47† 1.4  0.6† 0.006
Values are %, mean  SD, or median (interquartile range). *Cachetic chronic HF versus noncachetic chronic HF. †p < 0.05 versus controls.
ALAT ¼ alanine aminotransferase; ANP ¼ atrial natriuretic peptide; ASAT ¼ aspartate aminotransferase; HF ¼ heart failure; NYHA ¼ New York Heart Association;
VO2 ¼ oxygen consumption.
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1094artery (IMA) weremeasured by high-resolution duplex
ultrasonography (8- to 5-MHz vector-array transducer,
HDI 5000; Philips Medical Systems, Andover, Massa-
chusetts) by a single observer. Blood ﬂow measure-
ments were performed 3 times in each patient, and the
mean of 3 measurements was used for statistical
analysis. In brief, the investigator measured the
diameter of the artery during systole from magniﬁed
B-mode longitudinal images of the artery. Blood ﬂow
measurements were calculated using the formula: p 
r2  TAMV  60, where r is the radius of the artery and
TAMV is the time-averaged mean velocity, as previ-
ously described (7). The angle between the Doppler
beam and the mesenteric artery was <60. Systolic
blood ﬂow in the SMA was assessable in 63 patients
and 23 controls. Systolic blood ﬂow in the IMA was
assessable in 56 patients and 23 controls, and ﬂow in
CT was measured in 53 patients and 20 controls.
Transcutaneous abdominal sonography (12-MHz
linear-array transducer, HDI 5000) was used to mea-
sure bowel wall thickness in the middle segment of
the sigmoid (in subjects #1 to #65), descending,
transverse, and ascending colon (subjects #7 to #65).
Measurement of the terminal ileum (subjects #7 to
#65) was performed 5 cm proximal to the ileocecal
valve. Because of obesity, the sigmoid colon was not
assessed in 3 subjects, the transverse colon was
not assessed in 3 subjects, the ascending colon wasnot assessed in 1 subject, and the terminal ileum
was not assessed in 1 subject. Patients were scanned
under identical conditions after overnight fasting.
Measurement of bowel wall thickness was carried
out in true cross and longitudinal sections of the
relaxed bowel by assessment of the anterior bowel
wall. Overall thickness of the bowel wall was
measured from the ﬁrst mucosal interface echo to the
ﬁrst serosal echo. Each measurement was repeated
3 times at different positions of the intestinal wall,
and the mean was calculated.
All sonographic recordings were performed in a stan-
dardized way, and the same experienced physician, who
was blinded to the subjects’ study groups, analyzed the
readings. The intraobserver coefﬁcient of variation for
intestinal ultrasound measurements of bowel wall thick-
ness repeated on consecutive days is 5%. Accuracy of
measurement is <0.2 mm for all segments.
Venous occlusion plethysmography was performed
to assess peripheral blood ﬂow and vascular capacity
using a plethysmograph (EC 6; Hokanson, Inc., Bel-
levue, Washington) in 55 patients and 17 control
subjects, as previously described (8). The subjects
rested in a supine position for at least 15 min, and
forearm blood ﬂow was determined using a mercury-
in-Silastic strain gauge (Hokanson). A cuff around the
right upper arm was connected to a rapid inﬂation
pump with an air source and solenoid valves, used to
TABLE 2 Systolic and Diastolic BF in the 3 Main Intestinal Arteries
Intestinal Blood Flow
(ml/min)
Controls
(n ¼ 25)
All Patients
With
Chronic HF
(n ¼ 65)
Patients With
Noncachectic
Chronic HF
(n ¼ 53)
Patients With
Cachectic
Chronic HF
(n ¼ 12)
p
Value*
Mean systolic BF
SMA 483 (272) 304 (224)† 343 (203)† 205 (148)† 0.001
IMA 86 (62) 49 (26)† 51 (30)† 39 (23)† 0.05
CT 542 (373) 377 (246)† 416 (219)† 234 (182)† 0.01
Peak systolic BF
SMA 2,779 (1,641) 1,696 (959)† 1,774 (889)† 1,142 (951)† 0.003
IMA 411 (315) 260 (165)† 265 (163)† 254 (115)† 0.20
CT 2,619 (1,462) 1,717 (978)† 1,822 (815) 1,249 (518)† 0.009
Mean diastolic BF
SMA 291 (161) 211 (159)† 214 (149) 158 (208)† 0.10
IMA 43 (30) 30 (22)† 30 (22)† 27 (27)† 0.10
CT 512 (360) 291 (261)† 308 (246)† 190 (197)† 0.05
Maximal diastolic BF
SMA 555 (312) 449 (341)† 445 (348) 465 (346)* 0.25
IMA 78 (50) 54 (47)† 58 (47) 52 (50) 0.75
CT 750 (760) 548 (390)† 636 (420) 473 (214)† 0.30
Minimal diastolic BF
SMA 376 (263) 266 (264) 266 (259) 272 (268) 0.70
IMA 72 (56) 38 (31)† 43 (30)† 33 (20)† 0.50
CT 526 (279) 346 (242)† 365 (250)† 297 (142)† 0.80
Arm resting BF,
ml/100 ml/min
4.6  2.3 3.1  1.9† 3.1  2.0† 3.0  1.2 0.90
Arm peak post-ischemic
BF, ml/100 ml/min
21.2  7.7 16.3  6.5† 17.0  6.7† 13.4  5.4† 0.09
Values are median (interquartile range) or mean  SD. *Cachetic chronic HF versus noncachetic chronic HF.
†p < 0.05 versus controls.
BF ¼ blood ﬂow; CT ¼ celiac trunk; HF ¼ heart failure; IMA ¼ inferior mesenteric artery; SMA ¼ superior
mesenteric artery.
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1095inﬂate and deﬂate the occlusion cuff rapidly to the
required pressure of 40 mm Hg. To measure the
peak forearm blood ﬂow, the cuff was inﬂated to
suprasystolic pressure (30 mm Hg above systolic
blood pressure) for 3 min. Blood ﬂow was measured
after release of the cuff in 10-second intervals for at
least 2 min. The highest ﬂow results were considered
to represent peak forearm blood ﬂow.
Results for plethysmography are given in milliliters
per 100 ml tissue per min. All assessments were per-
formed in a dedicated, quiet room between 9 and 10
AM to prevent data bias from noise and circadian
rhythms.
GI symptoms were assessed with the Gastrointes-
tinal Symptom Rating Scale questionnaire, which was
completed by 59 patients and 18 control subjects (9).
Items include abdominal pain, reﬂux syndrome, diar-
rhea syndrome, indigestion syndrome, and con-
stipation syndrome (10) and have good internal
consistency, reliability, construct validity, and
responsiveness (9).
Mucosal bacterial bioﬁlm was assessed by ﬂuores-
cence in situ hybridization in biopsies taken during
sigmoidoscopy in 22 patients with chronic HF and
20 control subjects, as previously described (3),
according to a well-established technique without
sedation after a glycerol enema.
Stool samples were available from 21 patients with
chronic HF and 17 control subjects. Total bacteria
and bacterial groups were studied by ﬂuorescence in
situ hybridization and epiﬂuorescence microscopy
in blinded fecal samples, as previously described
(11). In 13 controls (subjects #10 to #22) and 12 patients
(subjects #9 to #20), intestinal blood ﬂowwas assessed
in that group. Blood immunoglobulin A (IgA)–anti–
lipopolysaccharide (LPS) were assessed in these pa-
tients and controls by enzyme-linked immunosorbent
assay (12,13).
In 27 patients and 18 control subjects, C-reactive
protein was measured. Plasma concentrations of
midregional proadrenomedullin and midregional
pro–atrial natriuretic peptide (ANP) were measured
by using a chemiluminescence immunoassay on the
Kryptor System (Brahms AG, Hennigsdorf/Berlin,
Germany), as previously described in detail (14,15).
STATISTICAL ANALYSIS. Statistical analysis was
performed using StatView version 5.0 (SAS Institute
Inc, Cary, North Carolina). Normality of distribution
was assessed using the Kolmogorov-Smirnov test.
Results are reported as mean  SD (indicating a
normal distribution of data; statistical comparisons
weremadeusing Student unpaired t tests) or asmedian
(interquartile range) (indicating a non-normaldistribution of data; statistical comparisonsweremade
using Mann-Whitney U tests). Analysis of variance,
Student unpaired t tests, Fisher exact tests, Pearson
simple regression, and logistic regression were used as
appropriate. Non-normally distributed data were log10
transformed to achieve a normal distribution where
indicated. Parameters that were signiﬁcantly different
between noncachectic and cachectic patients were
tested using multivariate regression analysis. Vari-
ables of interest were adjusted for age and sex as
indicated. A 2-tailed p value #0.05 was considered
signiﬁcant in all analyses.
RESULTS
There were no signiﬁcant differences between control
subjects and patients with chronic HF in terms of age
and sex (Table 1). As expected, patients had lower
LVEFs and peak oxygen consumption. Patients with
cardiac cachexia had lower body mass indexes and
were hemodynamically more severely compromised,
as reﬂected by lower peak oxygen consumption,
lower LVEFs, and higher blood levels of pro-ANP
Pro ANP in Blood (log[nmol/l])
3.5
r=0.3
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FIGURE 1 Blood Concentrations of Pro-ANP
Correlation of blood concentrations of pro–atrial natriuretic
peptide (ANP) (log [nmol/l]) with intestinal mean systolic blood
ﬂow in the (A) superior mesenteric artery (SMA) (log[ml/min]) in
55 patients and (B) in the celiac trunk (CT) (log[ml/min]) in 46
patients.
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1096compared with patients without cachexia (Table 1).
Patients with HF had higher blood concentration of
white blood cells compared with control subjects
(Table 1). Serum concentrations of C-reactive protein
were higher in patients compared with controls, with
the highest levels in cachectic patients compared
with noncachectic patients (Table 1).
INTESTINAL BLOOD FLOW. Patients with chronic HF
had lower mean and peak systolic blood ﬂow in the
SMA, IMA, and CT compared with control subjects
(Table 2). The lowest systolic blood ﬂow in the SMA,
IMA, and CT was in patients with cardiac cachexia,
with ﬂow reductions of 58%, 55%, and 57%, respec-
tively, compared with control subjects. Lower mean
systolic ﬂow in the SMA and CT was correlated with
the severity of HF in patients, according to higher
blood pro-ANP (Figures 1A and 1B). We did not detect
any stenoses of the mesenteric arteries or CT in either
patients or controls.
Mean diastolic blood ﬂow was lower in the CT and
IMA in patients compared with controls (Table 2).
There was a trend toward lower diastolic ﬂow in the
CT in patients with more severe HF according to
blood pro-ANP (r ¼ 0.25, p ¼ 0.096). Lower maximal
diastolic ﬂow and a trend toward lower minimal dia-
stolic ﬂow in the SMA were correlated with the
severity of HF in patients according to higher blood
pro-ANP (r ¼ 0.3, p < 0.03, and r ¼ 0.25, p ¼ 0.077).
In patients with HF, both resting arterial limb
blood ﬂow (arm) and peak post-ischemic ﬂow were
reduced, the latter indicating impaired vasodilator
capacity due to endothelial dysfunction compared
to controls (Table 2). Higher blood midregional pro-
adrenomedullin levels in patients underlined
impaired endothelial function in our patient group
(Table 1). However, there was no correlation of arm
blood ﬂow and intestinal blood ﬂow (p > 0.12 for all).
Arm blood pressure was not correlated with intestinal
blood ﬂow either (p > 0.40 for all).
BOWEL WALL THICKNESS. Patients had increased
bowel wall thickness in the terminal ileum, repre-
senting the small bowel, ascending colon, transverse
colon, descending colon, and sigmoid colon, com-
pared with control subjects (p < 0.01 for all; Table 3).
However, bowel wall thickness was not correlated
with patients’ edema status at lower leg and lower
arterial intestinal blood ﬂow.
GI SYMPTOMS. Compared with controls, patients
more often reported feelings of repletion (34 of 58 vs.
4 of 18, p ¼ 0.014), burping (15 of 59 vs. 0 of 18,
p ¼ 0.016), ﬂatulence (43 of 59 vs. 8 of 18, p ¼ 0.03),
and murmurs from the intestine (34 of 59 vs. 5 of 18,
p ¼ 0.027). In cachectic versus noncachectic patients,burping was more frequent and more severe (5 of
11 vs. 8 of 46, p < 0.05, and 1.8  0.4 vs. 1.3  0.3,
p ¼ 0.01), and murmurs from the intestine were, as a
trend, more severe (p < 0.08). Nausea and vomiting,
if present, were more severe as well (2.25  0.5 vs.
1.1  0.1, p < 0.02).
In those patients with abdominal discomfort, we
found lower mean systolic ﬂow in the CT (274  36 vs.
480  38 ml/min, p ¼ 0.02). In univariate regression,
both high NYHA class and low CT ﬂow were corre-
lated with abdominal discomfort (p < 0.04 for all).
Patients with intestinal murmurs had greater
bowel wall thickness of the sigmoid and descending
colon (0.23  0.017 cm vs. 0.18  0.01 cm, p ¼ 0.03,
TABLE 3 Bowel Wall Thickness of Terminal Ileum, Ascending Colon, Transverse Colon,
Descending Colon, and Sigmoid in Noncachectic and Cachectic Patients With Chronic HF
and Control Subjects
Bowel Wall
Thickness
(mm)
Controls
(n ¼ 25)
Patients With
Noncachectic Chronic HF
(n ¼ 51)
Patients With
Cachectic Chronic HF
(n ¼ 12)
p
Value*
Terminal ileum 1.0  0.3 1.3  0.4† 1.3  0.4† 0.0005
Ascending colon 1.2  0.5 1.6  0.6† 1.6  0.4† 0.008
Transverse colon 1.2  0.4 1.6  0.5† 1.5  0.3† 0.005
Descending colon 1.4  0.6 1.9  0.7† 1.9  0.5† 0.003
Sigmoid colon 1.5  0.6 2.1  0.9† 2.0  0.6† 0.005
Values are mean  SD. *Patients with chronic HF versus controls. †p < 0.05 versus controls.
HF ¼ heart failure.
TABLE 4 Concentration of Bacteria in Patients With Chronic HF and Control Subjects
Concentration
(count/g in stool)
Controls
(n ¼ 17)
Patients With Chronic HF
(n ¼ 21)
p
Value
Total bacteria 22  107 (72  107) 23  107 (115  107) 0.80
Aerobes 0.1  107 (1.0  107) 0.2  107 (0.9  107) 0.80
Gram-negative aerobes 0.6  105 (1.8  105) 0.5  105 (3.5  105) 0.80
Anaerobes 22  107 (68  107) 23  107 (115 107) 0.70
Anaerobes/total bacteria 1.0 (0.07) 1.0 (0.13) 0.50
Values are median (interquartile range).
HF ¼ heart failure.
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1097and 0.20  0.014 cm vs. 0.16  0.01 cm, p ¼ 0.04) and
similar bowel wall thickness of the terminal ileum
and the ascending colon (p > 0.20 for all).
There was a consistent trend toward increased
heartburn, reﬂux, and constipation in patients with
chronic HF compared with controls (21 of 59 vs. 2 of
18, p ¼ 0.075; 21 of 59 vs. 2 of 18, p ¼ 0.075; and
15 of 58 vs. 1 of 18, p ¼ 0.097). However, pain in the
upper abdomen (14 of 58 vs. 2 of 18, p ¼ 0.30),
defecation frequency (2 of 18 vs. 13 of 56, p ¼ 0.30),
and nausea or vomiting (13 of 59 vs. 2 of 18,
p ¼ 0.50) were similarly reported in patients and
controls.
STOOL BACTERIA. Concentrations and proportions
of both anaerobic and aerobic bacteria in the stool
were similar in patients and controls (Table 4). The
number and composition of stool bacteria did not
reﬂect the higher concentration of mostly anaerobic
bacteria in the mucosal bioﬁlm of patients or the
increased proportion of strictly anaerobic Eubacte-
rium rectale, Bacteroides/Prevotella, and Fusobacte-
rium prausnitzii in the bioﬁlm of patients (r ¼ 0.4 and
r ¼ 0.3, p ¼ 0.12, p > 0.17, p > 0.50, and p > 0.37,
respectively). This ﬁnding points to an increase in
bacteria restricted to the juxtamucosal zone. The
concentration of total stool bacteria, aerobes, Gram-
negative aerobes, anaerobes, lactobacilli, entero-
cocci, Bacteroides, biﬁdobacteria, or yeast in stool was
not associated with lower intestinal blood ﬂow
(p > 0.10 for all).
In contrast, a higher proportion of the strictly
anaerobic E. rectale in the juxtamucosal bioﬁlm of the
sigmoid colon in patients was correlated with lower
systolic ﬂow in the IMA supplying the sigmoid colon
(r ¼ 0.64, p ¼ 0.047).
In 13 of 22 patients with high concentrations of
juxtamucosal bacteria of $108/ml, there was a strong
trend toward an association of increased growth of
juxtamucosal bacteria and serum concentrations of
IgA-anti-LPS (r ¼ 0.55, p ¼ 0.05) (Figure 2). Luminal
stool bacteria was not correlated with serum IgA-LPS
antibodies.
Lower blood ﬂow in the CT was correlated with
higher serum IgA-LPS antibodies (r ¼ 0.76, p < 0.02)
(Figure 3) and with higher serum C-reactive protein
(r ¼ 0.61, p ¼ 0.003) (Figure 4). Lower intestinal blood
ﬂow in the SMA was associated with higher serum C-
reactive protein in patients as well (r ¼ 0.43, p ¼ 0.02)
(Figure 4).
CORRELATES OF THE PRESENCE OF CACHEXIA. In
univariate logistic regression, lower LVEF, higher
blood pro-ANP, higher NYHA class, lower intestinal
ﬂow in the CT or SMA, and a trend toward lowerintestinal ﬂow in IMA were correlated with the pres-
ence of cachexia (Table 5). These correlations of lower
LVEF, higher blood pro-ANP, higher NYHA class,
and lower intestinal ﬂow in the CT or SMA with
the presence of cachexia remained signiﬁcant after
adjustment for age and sex (p < 0.02, p < 0.003, p <
0.008, p < 0.03, or p < 0.01, respectively).
In contrast, age, sex, resting arterial limb blood
ﬂow (arm), and bowel wall thickness were not corre-
lated with the presence of cachexia serving as the
dependent variable (Table 5).
In multivariate regression analysis, lower intesti-
nal blood ﬂow in the SMA and CT (p < 0.04 for all)
and a trend toward lower intestinal blood ﬂow in the
IMA (p < 0.058) were independently associated with
the presence of cardiac cachexia in distinct models,
each adjusted for NYHA functional class, LVEF, and
pro-ANP. The probability of having cachexia for in-
testinal ﬂows, each adjusted for NYHA functional
class, LVEF, and pro-ANP, was 0.1 for an increase in
CT ﬂow (odds ratio: 0.1; 95% conﬁdence interval:
0.02 to 0.8), 0.2 for an increase in SMA ﬂow (odds
ratio: 0.2; 95% conﬁdence interval: 0.04 to 0.8), and
0.4 for an increase in IMA ﬂow (odds ratio: 0.4; 95%
conﬁdence interval: 0.1 to 1.0).
There was a trend toward higher NYHA func-
tional class to be independently associated with the
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FIGURE 2 Correlation of Concentration of Bacteria in
Mucosal Bioﬁlm of the Sigmoid Colon in Patients, With
Their Serum Concentrations of IgA-Anti-LPS
IgA ¼ immunoglobulin A; LPS ¼ lipopolysaccharide.
Sandek et al. J A C C V O L . 6 4 , N O . 1 1 , 2 0 1 4
Intestinal Blood Flow in Heart Failure S E P T E M B E R 1 6 , 2 0 1 4 : 1 0 9 2 – 1 0 2
1098presence of cardiac cachexia in models including
either CT or SMA ﬂow (p < 0.097).
DISCUSSION
This is the ﬁrst study to evaluate blood ﬂow in all 3
arteries supplying the stomach and the small and
large intestines in patients with and without cardiac3.5
n= 9
r= 0.76
p< 0.02
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FIGURE 3 Mean Systolic Blood Flow in the Celiac Trunk
Correlation of mean systolic blood ﬂow in the celiac trunk in
9 patients, with their serum concentrations of immunoglobulin A
(IgA)–anti–lipopolysaccharide (LPS).
FIGURE 4 Lower Mean Systolic Blood Flow in Patients With
Heart Failure
Correlation of lower mean systolic blood ﬂow (A) in the celiac
trunk (CT) and (B) in the superior mesenteric artery (SMA) with
higher serum C-reactive protein in patients with heart failure.cachexia (Central Illustration). Endothelial function of
the forearm vessels revealed both lower resting blood
ﬂow and lower post-ischemic ﬂow in patients with HF
compared with control subjects. A higher concentra-
tion of juxtamucosal anaerobic bacteria in the sig-
moid colon in patients was correlated with a higher
systemic concentration of anti-LPS IgA antibodies.
Furthermore, there was an increase in GI symp-
toms in patients compared with controls. Patients
more often reported feelings of repletion, burping,
ﬂatulence, and murmurs from the intestine. Symp-
toms were most pronounced in cachectic patients.
Patients with abdominal discomfort had lower mean
systolic ﬂow in the CT.
Impaired intestinal blood ﬂow correlated with
severity of HF and was in accord with greater
TABLE 5 Logistic Regression Model With Presence of Cachexia Serving as the
Dependent Variable
Univariate OR 95% CI p Value
Age, per 1-yr increase 0.98 0.92–1.05 0.50
Female 2.30 0.26–20.16 0.50
NYHA functional class, per 1-class increase 4.80 1.32–17.53 0.02
LVEF, per 1% increase 0.89 0.81–0.97 0.01
Intestinal blood ﬂow
CT, per log Fmean systolic/SD 0.324 0.129–0.815 0.017
SMA, per log Fmean systolic/SD 0.361 0.174–0.751 0.006
IMA, per log Fmean systolic/SD 0.519 0.250–1.078 0.079
Pro-ANP, per log nmol/l/SD 5.448 1.704–17.417 0.004
Arm resting blood ﬂow, per ml/100 ml/min 0.97 0.68–1.39 0.90
Bowel wall thickness, per 1-mm increase
Sigmoid colon 0.89 0.41–1.92 0.80
Descending colon 1.10 0.44–2.75 0.80
Transverse colon 0.69 0.17–2.88 0.60
Ascending colon 0.89 0.26–3.00 0.80
Terminal ileum 1.01 0.17–5.90 0.90
CI ¼ conﬁdence interval; LVEF ¼ left ventricular ejection fraction; OR ¼ odds ratio; other abbreviations as in
Tables 1 and 2.
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1099thickness of the bowel wall in patients with chronic
HF, suggestive of bowel wall edema. Patients with
intestinal murmurs had the greatest bowel wall
thickness of the sigmoid and descending colon.
However, patients did not have symptoms of
mesenteric ischemia, such as abdominal pain,
diarrhea, or obvious intestinal bleeding. The only
symptoms found were minor and could be ascribed to
changes in intestinal motor function.
MUCOSAL BIOFILM. One explanation for the
increased number of bacteria in the mucosal bioﬁlm
is that entirely new phylotypes of bacteria are present
in patients with HF. Some differences were found,
such as that a greater proportion of patients with
chronic HF had Bacteroides/Prevotella, E. rectale, and
F. prausnitzii (3), all representing species of normal
intestinal ﬂora. Overall, the range of bacteria within
bioﬁlm was broadly similar in patients and controls.
It is therefore likely that the environment in the
mucosal bioﬁlm is altered in patients with HF in such
a way that the growth of bacteria is encouraged. In
particular, the higher occurrence rate of the strictly
anaerobic E. rectale group and the strictly anaerobic
F. prausnitzii in intestinal bioﬁlm indicates better
conditions for these speciﬁc anaerobes directly at the
surface of the mucus membrane in patients with
chronic HF.
A major candidate for the cause of the environ-
mental change in the mucosal bioﬁlm is reduced
mesenteric blood ﬂow and endothelial dysfunction,
as we report here. The correlation of lower systolic
ﬂow in the IMA supplying the sigmoid colon with the
higher proportion of juxtamucosal strictly anaerobic
E. rectale found in patients indicates this. Reduced
intestinal blood ﬂow results in limited oxygen supply
to the mucosa, which may cause this selective
enrichment of obligate anaerobic gut ﬂora in patients
with HF.
The increase in bioﬁlm bacteria on the luminal side
of the gut wall seems to be an initial local mucosal
phenomenon not resulting in changes of the global
composition of stool, at least in patients with HF in
stable condition. The ﬁnding that stool bacteria did
not correlate with the total amount of bacteria in the
mucosal bioﬁlm of the sigmoid colon indicates future
studies must be undertaken on samples of mucosal
bioﬁlm.
GI SYMPTOMS. Consequences of reduced blood
ﬂow do not seem to be restricted to the mucosal
bioﬁlm, as the increased GI symptoms described
here suggest motor dysfunction of the intestine
(Central Illustration). As of now, the precise patho-
physiological basis of the symptoms of burping,ﬂatulence, sensation of repletion, and intestinal
murmur is not yet known, although a disturbance in
motor patterns is a possible explanation. Strictly
anaerobic E. rectale, a bacterial species we found to be
higher in proportion at the surface of the mucus
membrane in the congestive HF group, is known to
produce high amounts of hydrogen gas and therefore
may contribute to the increase in intestinal symptoms
such as ﬂatulence and intestinal murmurs in patients
with HF. The fact that a higher proportion of juxta-
mucosal E. rectale in patients with HF was correlated
with lower systolic ﬂow in the IMA supplying the
sigmoid colon suggests that reduced intestinal blood
ﬂow in patients with HF may contribute to a consec-
utive increase in juxtamucosal bacteria, thereby pro-
moting intestinal symptoms (Central Illustration).
It cannot be completely ruled out that inﬂuences of
long-term medications or a diet rich in carbohydrates
and ﬁbers contribute to these symptoms in patients
with HF, though we have no evidence that patients
with HF had diets higher in ﬁber than controls.
However, the fact that lower CT blood ﬂow was
correlated with abdominal discomfort suggests that
the GI symptoms may furthermore be due to motor
defects in the gut secondary to ischemia.
Altered arterial intestinal blood ﬂow has not been
directly described in patients with chronic HF in
stable condition. Intramucosal acidosis occurs in
about 50% of patients with circulatory failure (16–18),
pointing indirectly to an inadequate oxygen supply
and intestinal ischemia (19). The present ﬁndings of
Increased venous congestion
Increased bowel 
wall thickness
(intestinal edema)
Reduced 
lipopolysaccharide
(LPS) clearance
Increased
translocation
of bacterial
products (LPS)
Congestive 
liver disease
Increased
immune activation
Increase in 
juxtamucosal bacteria
Intestinal motor
dysfunction
Absorptive
dysfunction
Absorptive
dysfunction
Intestinal
symptoms
CARDIAC CACHEXIA
CHRONIC HEART FAILURE
CENTRAL ILLUSTRATION Pathophysiology of Cardiointestinal Syndrome
The relationship between chronic heart failure, cardiac cachexia, and gastrointestinal symptoms.
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1100diminished mean and peak systolic resting intestinal
blood ﬂow are likely to cause decreased oxygen
supply, and this latent intestinal ischemia thereby
challenges mucosal barrier integrity.
INTERACTION BETWEEN MUCOSAL INTESTINAL
BACTERIA AND THE IMMUNE SYSTEM. The intestine
investigated in this study is a highly sensitive region,
because the bowel wall establishes the barrier to a
huge amount of bacteria that are potentially immu-
nogenic to the host when entering the circulation. As
a potential result, patients with chronic HF have been
reported to display higher blood concentrations
IgA–anti–Escherichia coli J5 endotoxin compared with
controls (3), reﬂecting higher endotoxin bioactivity
and mucosal interaction in patients.
Higher endotoxin (LPS) concentrations have been
found in the hepatic veins compared with the left
ventricle during acute HF, suggestive of bacterial
translocation from the gut into the systemic circula-
tion (20). Therefore, the intestine is a very likely
reason for triggering IgA antibodies against LPS.
The present study shows a correlation between
lower blood ﬂow in the CT and higher systemic serum
LPS IgA antibodies and an association of increased
growth of juxtamucosal bacteria with a higher serum
concentration of IgA anti-LPS in patients with HF.
Above a certain threshold, the more bacteria there are
in the bioﬁlm, the higher the LPS antibodies. Thisﬁnding points to an interaction between mucosal
intestinal bacteria and the immune system (Central
Illustration) in patients with HF in stable condition
that may contribute to the prognostically relevant
systemic inﬂammation in HF.
However, the extent of contribution to the sys-
temic increase in proinﬂammatory mediators cannot
be concluded from this study.
BOWEL WALL THICKNESS. Reduced arterial intesti-
nal blood ﬂow in patients is in accord with greater
bowel wall thickness of both the small and large
intestines, suggestive of bowel wall edema due to
hemodynamic perturbations. Increased bowel wall
thickness is a frequent ﬁnding in various conditions,
such as acute ischemic colitis (21), inﬂammatory
bowel disease (22), and food hypersensitivity (23).
The ﬁnding of increased bowel wall thickness was
previously described in 22 patients with chronic sta-
ble HF. In this study of 65 patients, we were able to
conﬁrm this ﬁnding of the thickened bowel wall in a
larger cohort and to investigate its relation to the
arterial perfusion in the corresponding intestinal
vessels and, furthermore, to intestinal symptoms in
HF. There was no direct correlation of diminished
arterial blood supply with the extension of swelling of
the intestinal wall, which points to cofactors, such as
venous congestion that may further inﬂuence the
degree of bowel wall edema.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Chronic HF is
associated with low-grade systemic inﬂammation and anabolic-
catabolic imbalance that leads to cardiac cachexia at the terminal
stage of the disease. Patients with chronic HF develop reduced
intestinal blood ﬂow and bowel wall edema that impede
absorptive function and permit bacterial overgrowth in the
mucus layer adjacent to the apical surface of the colonic mucosa.
TRANSLATIONAL OUTLOOK: Research is needed to deter-
mine whether interventions that specially increase mesenteric
blood ﬂow inhibit the growth of juxtamucosal bacteria, reduce
inﬂammation and GI symptoms, and ameliorate cardiac cachexia
in patients with advanced HF.
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1101Greater bowel wall thickness of the sigmoid and
descending colon was associated with increased
intestinal murmurs, indicating a contribution of
swelling of the intestine to intestinal symptoms.
CORRELATION OF INTESTINAL BLOOD FLOW WITH
FOREARM BLOOD FLOW. Impaired vasodilator
capacity due to endothelial dysfunction may further
aggravate this critical perfusion of the intestinal
mucosa. Impaired vasodilator capacity was indicated
in our patients by lower forearm post-ischemic ﬂow.
Higher blood midregional proadrenomedullin levels
in patients further underscore the suspected endo-
thelial dysfunction. However, there was no correla-
tion of this reduced arterial forearm blood ﬂow with
the reduced intestinal ﬂow, reﬂecting adaptive
mechanisms in the different zones within the
vascular bed. Arm blood pressure was not correlated
with reduced intestinal ﬂow either. This indicates
that both arm blood ﬂow and blood pressure are
insufﬁcient markers of decreased intestinal ﬂow and
points to a need for the assessment of intestinal ﬂow
in patients with HF.
CARDIAC CACHEXIA. Cachexia is a serious compli-
cation of advanced HF and among the most important
predictors of prognosis. Cachectic patients who had
more severe HF in this study, as reﬂected by higher
blood concentration of pro-ANP, showed both more
severe nausea or vomiting and burping and the lowest
intestinal blood ﬂow. In multivariate regression
analysis with limited statistical power, the lower in-
testinal blood ﬂow in the SMA and the CT and the trend
toward lower intestinal blood ﬂow in the IMA were
correlates of the presence of cardiac cachexia. This
suggests a contribution of restricted arterial intestinal
blood ﬂow to cardiac cachexia (Central Illustration).STUDY LIMITATIONS. The number of participants in
this study is limited. Larger studies are required to
provide further insight into intestinal alterations in
heart failure.
CONCLUSIONS
Intestinal arterial blood ﬂow is reduced in patients
with chronic HF, which may contribute to increased
growth of juxtamucosal bacteria, inﬂammation, GI
symptoms, and cardiac cachexia complicating
advanced stages of HF.
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